Intensity-Modulated and Image-Guided Radiotherapy in Patients with Locally Advanced Inoperable Pancreatic Cancer after Preradiation Chemotherapy
Background. Radiotherapy (RT) in patients with pancreatic cancer is still a controversial subject and its benefit in inoperable stages of locally advanced pancreatic cancer (LAPC), even after induction chemotherapy, remains unclear. Modern radiation techniques such as image-guided radiotherapy (IGRT...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2014-01-01
|
| Series: | The Scientific World Journal |
| Online Access: | http://dx.doi.org/10.1155/2014/452089 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850221325815119872 |
|---|---|
| author | M. Sinn R. Ganeshan R. Graf U. Pelzer J. M. Stieler J. K. Striefler M. Bahra P. Wust H. Riess |
| author_facet | M. Sinn R. Ganeshan R. Graf U. Pelzer J. M. Stieler J. K. Striefler M. Bahra P. Wust H. Riess |
| author_sort | M. Sinn |
| collection | DOAJ |
| description | Background. Radiotherapy (RT) in patients with pancreatic cancer is still a controversial subject and its benefit in inoperable stages of locally advanced pancreatic cancer (LAPC), even after induction chemotherapy, remains unclear. Modern radiation techniques such as image-guided radiotherapy (IGRT) and intensity-modulated radiotherapy (IMRT) may improve effectiveness and reduce radiotherapy-related toxicities. Methods. Patients with LAPC who underwent radiotherapy after chemotherapy between 09/2004 and 05/2013 were retrospectively analyzed with regard to preradiation chemotherapy (PRCT), modalities of radiotherapy, and toxicities. Progression-free (PFS) and overall survival (OS) were estimated by Kaplan-Meier curves. Results. 15 (68%) women and 7 men (median age 64 years; range 40–77) were identified. Median duration of PRCT was 11.1 months (range 4.3–33.0). Six patients (27%) underwent conventional RT and 16 patients (73%) advanced IMRT and IGRT; median dosage was 50.4 (range 9–54) Gray. No grade III or IV toxicities occurred. Median PFS (estimated from the beginning of RT) was 5.8 months, 2.6 months in the conventional RT group (conv-RT), and 7.1 months in the IMRT/IGRT group (P=0.029); median OS was 11.0 months, 4.2 months (conv-RT), and 14.0 months (IMRT/IGRT); P=0.141. Median RT-specific PFS for patients with prolonged PRCT > 9 months was 8.5 months compared to 5.6 months for PRCT < 9 months (P=0.293). This effect was translated into a significantly better median RT-specific overall survival of patients in the PRCT > 9 months group, with 19.0 months compared to 8.5 months in the PRCT < 9 months group (P=0.049). Conclusions. IGRT and IMRT after PRCT are feasible and effective options for patients with LAPC after prolonged preradiation chemotherapy. |
| format | Article |
| id | doaj-art-6d46f28827fa4c7db2522cb609e710f7 |
| institution | OA Journals |
| issn | 2356-6140 1537-744X |
| language | English |
| publishDate | 2014-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | The Scientific World Journal |
| spelling | doaj-art-6d46f28827fa4c7db2522cb609e710f72025-08-20T02:06:44ZengWileyThe Scientific World Journal2356-61401537-744X2014-01-01201410.1155/2014/452089452089Intensity-Modulated and Image-Guided Radiotherapy in Patients with Locally Advanced Inoperable Pancreatic Cancer after Preradiation ChemotherapyM. Sinn0R. Ganeshan1R. Graf2U. Pelzer3J. M. Stieler4J. K. Striefler5M. Bahra6P. Wust7H. Riess8Department of Medical Oncology and Haematology, Charité, Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, GermanyDepartment of Medical Oncology and Haematology, Charité, Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, GermanyDepartment of Radiooncology, Charité, Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, GermanyDepartment of Medical Oncology and Haematology, Charité, Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, GermanyDepartment of Medical Oncology and Haematology, Charité, Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, GermanyDepartment of Medical Oncology and Haematology, Charité, Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, GermanyDepartment of General, Visceral and Transplantation Surgery, Charité, Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, GermanyDepartment of Radiooncology, Charité, Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, GermanyDepartment of Medical Oncology and Haematology, Charité, Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, GermanyBackground. Radiotherapy (RT) in patients with pancreatic cancer is still a controversial subject and its benefit in inoperable stages of locally advanced pancreatic cancer (LAPC), even after induction chemotherapy, remains unclear. Modern radiation techniques such as image-guided radiotherapy (IGRT) and intensity-modulated radiotherapy (IMRT) may improve effectiveness and reduce radiotherapy-related toxicities. Methods. Patients with LAPC who underwent radiotherapy after chemotherapy between 09/2004 and 05/2013 were retrospectively analyzed with regard to preradiation chemotherapy (PRCT), modalities of radiotherapy, and toxicities. Progression-free (PFS) and overall survival (OS) were estimated by Kaplan-Meier curves. Results. 15 (68%) women and 7 men (median age 64 years; range 40–77) were identified. Median duration of PRCT was 11.1 months (range 4.3–33.0). Six patients (27%) underwent conventional RT and 16 patients (73%) advanced IMRT and IGRT; median dosage was 50.4 (range 9–54) Gray. No grade III or IV toxicities occurred. Median PFS (estimated from the beginning of RT) was 5.8 months, 2.6 months in the conventional RT group (conv-RT), and 7.1 months in the IMRT/IGRT group (P=0.029); median OS was 11.0 months, 4.2 months (conv-RT), and 14.0 months (IMRT/IGRT); P=0.141. Median RT-specific PFS for patients with prolonged PRCT > 9 months was 8.5 months compared to 5.6 months for PRCT < 9 months (P=0.293). This effect was translated into a significantly better median RT-specific overall survival of patients in the PRCT > 9 months group, with 19.0 months compared to 8.5 months in the PRCT < 9 months group (P=0.049). Conclusions. IGRT and IMRT after PRCT are feasible and effective options for patients with LAPC after prolonged preradiation chemotherapy.http://dx.doi.org/10.1155/2014/452089 |
| spellingShingle | M. Sinn R. Ganeshan R. Graf U. Pelzer J. M. Stieler J. K. Striefler M. Bahra P. Wust H. Riess Intensity-Modulated and Image-Guided Radiotherapy in Patients with Locally Advanced Inoperable Pancreatic Cancer after Preradiation Chemotherapy The Scientific World Journal |
| title | Intensity-Modulated and Image-Guided Radiotherapy in Patients with Locally Advanced Inoperable Pancreatic Cancer after Preradiation Chemotherapy |
| title_full | Intensity-Modulated and Image-Guided Radiotherapy in Patients with Locally Advanced Inoperable Pancreatic Cancer after Preradiation Chemotherapy |
| title_fullStr | Intensity-Modulated and Image-Guided Radiotherapy in Patients with Locally Advanced Inoperable Pancreatic Cancer after Preradiation Chemotherapy |
| title_full_unstemmed | Intensity-Modulated and Image-Guided Radiotherapy in Patients with Locally Advanced Inoperable Pancreatic Cancer after Preradiation Chemotherapy |
| title_short | Intensity-Modulated and Image-Guided Radiotherapy in Patients with Locally Advanced Inoperable Pancreatic Cancer after Preradiation Chemotherapy |
| title_sort | intensity modulated and image guided radiotherapy in patients with locally advanced inoperable pancreatic cancer after preradiation chemotherapy |
| url | http://dx.doi.org/10.1155/2014/452089 |
| work_keys_str_mv | AT msinn intensitymodulatedandimageguidedradiotherapyinpatientswithlocallyadvancedinoperablepancreaticcancerafterpreradiationchemotherapy AT rganeshan intensitymodulatedandimageguidedradiotherapyinpatientswithlocallyadvancedinoperablepancreaticcancerafterpreradiationchemotherapy AT rgraf intensitymodulatedandimageguidedradiotherapyinpatientswithlocallyadvancedinoperablepancreaticcancerafterpreradiationchemotherapy AT upelzer intensitymodulatedandimageguidedradiotherapyinpatientswithlocallyadvancedinoperablepancreaticcancerafterpreradiationchemotherapy AT jmstieler intensitymodulatedandimageguidedradiotherapyinpatientswithlocallyadvancedinoperablepancreaticcancerafterpreradiationchemotherapy AT jkstriefler intensitymodulatedandimageguidedradiotherapyinpatientswithlocallyadvancedinoperablepancreaticcancerafterpreradiationchemotherapy AT mbahra intensitymodulatedandimageguidedradiotherapyinpatientswithlocallyadvancedinoperablepancreaticcancerafterpreradiationchemotherapy AT pwust intensitymodulatedandimageguidedradiotherapyinpatientswithlocallyadvancedinoperablepancreaticcancerafterpreradiationchemotherapy AT hriess intensitymodulatedandimageguidedradiotherapyinpatientswithlocallyadvancedinoperablepancreaticcancerafterpreradiationchemotherapy |